{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:09:11Z","timestamp":1790759351222,"version":"4.1.0"},"reference-count":59,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"abstract":"<jats:p>Prader-Willi syndrome (PWS) has a biphasic clinical phenotype with failure to thrive in the neonatal period followed by hyperphagia and severe obesity commencing in childhood among other endocrinological and neurobehavioral abnormalities. The syndrome results from loss of function of several clustered, paternally expressed genes in chromosome 15q11-q13. PWS is assumed to result from a hypothalamic defect, but the pathophysiological basis of the disorder is unknown. We hypothesize that a fetal developmental abnormality in PWS leads to the neonatal phenotype, whereas the adult phenotype results from a failure in compensatory mechanisms. To address this hypothesis and better characterize the neonatal failure to thrive phenotype during postnatal life, we studied a transgenic deletion PWS (TgPWS) mouse model that shares similarities with the first stage of the human syndrome. TgPWS mice have fetal and neonatal growth retardation associated with profoundly reduced insulin and glucagon levels. Consistent with growth retardation, TgPWS mice have deregulated liver expression of IGF system components, as revealed by quantitative gene expression studies. Lethality in TgPWS mice appears to result from severe hypoglycemia after postnatal d 2 after depletion of liver glycogen stores. Consistent with hypoglycemia, TgPWS mice appear to have increased fat oxidation. Ghrelin levels increase in TgPWS reciprocally with the falling glucose levels, suggesting that the rise in ghrelin reported in PWS patients may be secondary to a perceived energy deficiency. Together, the data reveal defects in endocrine pancreatic function as well as glucose and hepatic energy metabolism that may underlie the neonatal phenotype of PWS.<\/jats:p>","DOI":"10.1210\/en.2005-0371","type":"journal-article","created":{"date-parts":[[2005,7,8]],"date-time":"2005-07-08T00:35:38Z","timestamp":1120782938000},"page":"4377-4385","source":"Crossref","is-referenced-by-count":48,"title":["Hormonal and Metabolic Defects in a Prader-Willi Syndrome Mouse Model with Neonatal Failure to Thrive"],"prefix":"10.1210","volume":"146","author":[{"given":"M.","family":"Stefan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Simmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Cummings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S.","family":"Ahima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. I.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. D.","family":"Nicholls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613105662300_R1","first-page":"1251","article-title":"Physical features of Prader-Willi syndrome in neonates.","volume":"144","author":"Aughton","year":"1990","journal-title":"Am J Dis Child"},{"key":"2020071613105662300_R2","first-page":"1","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"1984","journal-title":"Curr Probl Pediatr."},{"key":"2020071613105662300_R3","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S1096-6374(00)80015-5","article-title":"Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion","volume":"B","author":"Pa\u0308rtsch","year":"2000","journal-title":"Growth Horm IGF Res Suppl."},{"key":"2020071613105662300_R4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.genom.2.1.153","article-title":"Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes","volume":"2","author":"Nicholls","year":"2001","journal-title":"Annu Rev Genomics Hum Genet."},{"key":"2020071613105662300_R5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s004310050832","article-title":"Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance","volume":"157","author":"Eiholzer","year":"1998","journal-title":"Eur J Pediatr."},{"key":"2020071613105662300_R6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1651-2227.1998.tb01380.x","article-title":"Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favorably","volume":"87","author":"Lindgren","year":"1998","journal-title":"Acta Paediatr."},{"key":"2020071613105662300_R7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3476(99)70418-X","article-title":"Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study","volume":"134","author":"Carrel","year":"1999","journal-title":"J Pediatr."},{"key":"2020071613105662300_R8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","article-title":"Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH","volume":"22","author":"Burman","year":"2001","journal-title":"Endocr Rev."},{"key":"2020071613105662300_R9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tem.2003.11.003","article-title":"Prader-Willi syndrome: advances in genetics, pathophysiology and treatment","volume":"15","author":"Goldstone","year":"2004","journal-title":"Trends Endocrinol Metab."},{"key":"2020071613105662300_R10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s004310050961","article-title":"Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome","volume":"157","author":"Eiholzer","year":"1998","journal-title":"Eur J Pediatr."},{"key":"2020071613105662300_R11","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0026-0495(96)90181-X","article-title":"Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.","volume":"45","author":"Schuster","year":"1996","journal-title":"Metabolism"},{"key":"2020071613105662300_R12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/er.2002-0029","article-title":"Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin","volume":"25","author":"Van der Lely","year":"2004","journal-title":"Endocr Rev."},{"key":"2020071613105662300_R13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nm0702-643","article-title":"Elevated plasma ghrelin levels in Prader Willi syndrome","volume":"8","author":"Cummings","year":"2002","journal-title":"Nat Med."},{"key":"2020071613105662300_R14","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1210\/jc.2002-020871","article-title":"High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome","volume":"87","author":"DelParigi","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"2020071613105662300_R15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/jc.2002-021052","article-title":"Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome","volume":"88","author":"Haqq","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"2020071613105662300_R16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jnnp.2004.039024","article-title":"Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI.","volume":"76","author":"Shapira","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020071613105662300_R17","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/378816","article-title":"Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi\/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons","volume":"73","author":"Chai","year":"2003","journal-title":"Am J Hum Genet."},{"key":"2020071613105662300_R18","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1093\/nar\/27.23.4577","article-title":"Concerted regulation and molecular evolution of the duplicated SNRPB\u2019\/B and SNRPN loci","volume":"27","author":"Gray","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"2020071613105662300_R19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ng1292-270","article-title":"A candidate mouse model for Prader-Willi syndrome which shows an absence of Snrpn expression","volume":"2","author":"Cattanach","year":"1992","journal-title":"Nat Genet."},{"key":"2020071613105662300_R20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0598-25","article-title":"A mouse model for Prader-Willi syndrome imprinting-centre mutations","volume":"19","author":"Yang","year":"1998","journal-title":"Nat Genet."},{"key":"2020071613105662300_R21","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.1073\/pnas.96.16.9258","article-title":"A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and Angelman syndromes","volume":"96","author":"Gabriel","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"2020071613105662300_R22","first-page":"11","author":"Keppler","year":"1983"},{"key":"2020071613105662300_R23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol."},{"key":"2020071613105662300_R24","first-page":"R610","article-title":"Temporal relationships between eating behavior and liver adenine nucleotides in rats treated with 2,5-AM","volume":"274","author":"Koch","year":"1998","journal-title":"Am J Physiol."},{"key":"2020071613105662300_R25","first-page":"443","author":"Ramirez","year":"1987"},{"key":"2020071613105662300_R26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ygeno.2005.02.004","article-title":"A non-imprinted Prader-Willi syndrome (PWS)-region gene regulates a different chromosomal domain in trans but the imprinted PWS loci do not alter genome-wide mRNA levels","volume":"85","author":"Stefan","year":"2005","journal-title":"Genomics."},{"key":"2020071613105662300_R27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/13828","article-title":"Disruption of the mouse Necdin gene results in early post-natal lethality","volume":"23","author":"Ge\u0301rard","year":"1999","journal-title":"Nat Genet."},{"key":"2020071613105662300_R28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2003.09.003","article-title":"Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment","volume":"14","author":"Ho\u0308ybye","year":"2004","journal-title":"Growth Horm IGF Res."},{"key":"2020071613105662300_R29","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jcem.87.8.8735","article-title":"Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity","volume":"87","author":"Ho\u0308ybye","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"2020071613105662300_R30","first-page":"801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr Rev."},{"key":"2020071613105662300_R31","first-page":"E662","article-title":"Simultaneous measurements of umbilical uptake, fetal utilization rate, and fetal turnover rate of glucose","volume":"240","author":"Hay Jr","year":"1981","journal-title":"Am J Physiol."},{"key":"2020071613105662300_R32","first-page":"E347","article-title":"Partition of maternal glucose production between conceptus and maternal tissues in sheep","volume":"245","author":"Hay Jr","year":"1983","journal-title":"Am J Physiol."},{"key":"2020071613105662300_R33","first-page":"E443","article-title":"Neonatal adaptation: greater sympathoadrenal response in preterm than full-term fetal sheep at birth","volume":"248","author":"Padbury","year":"1985","journal-title":"Am J Physiol."},{"key":"2020071613105662300_R34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2788.1993.tb00318.x","article-title":"Growth and developmental patterns in Prader-Willi syndrome","volume":"37","author":"Ehara","year":"1993","journal-title":"J Intellect Disabil Res."},{"key":"2020071613105662300_R35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00210291","article-title":"Genotype-phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome","volume":"96","author":"Gillessen-Kaesbach","year":"1995","journal-title":"Hum Genet."},{"key":"2020071613105662300_R36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1096-8628(20001113)95:2<130::AID-AJMG7>3.0.CO;2-R","article-title":"Standard growth curves for Japanese patients with Prader-Willi syndrome","volume":"95","author":"Nagai","year":"2000","journal-title":"Am J Med Genet."},{"key":"2020071613105662300_R37","first-page":"955","article-title":"Genetics of mouse growth","volume":"42","author":"Efstratiadis","year":"1998","journal-title":"Int J Dev Biol."},{"key":"2020071613105662300_R38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/dbio.2000.9975","article-title":"Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth","volume":"229","author":"Lupu","year":"2001","journal-title":"Dev Biol."},{"key":"2020071613105662300_R39","first-page":"173","article-title":"The role of insulin in prenatal growth","volume":"12","author":"Fowden","year":"1989","journal-title":"J Dev Physiol."},{"key":"2020071613105662300_R40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1530\/acta.0.1280140","article-title":"Cortisol increases plasma insulin-like growth factor binding protein-1 in humans","volume":"128","author":"Conover","year":"1993","journal-title":"Acta Endocrinol (Copenh.)."},{"key":"2020071613105662300_R41","first-page":"1355","article-title":"Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans","volume":"74","author":"Conover","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"2020071613105662300_R42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3181\/00379727-216-44182","article-title":"Insulin-like growth factor binding protein-1: recent findings and new directions","volume":"216","author":"Lee","year":"1997","journal-title":"Proc Soc Exp Biol Med."},{"key":"2020071613105662300_R43","first-page":"1561","article-title":"Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein 1 gene transcription by hormones and provision of amino acids in rat hepatocytes","volume":"7","author":"Pao","year":"1993","journal-title":"Mol Endocrinol."},{"key":"2020071613105662300_R44","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1210\/endo.138.7.5282","article-title":"Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth.","volume":"138","author":"Gay","year":"1997","journal-title":"Endocrinology"},{"key":"2020071613105662300_R45","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1242\/dev.129.17.4065","article-title":"Hoxa5 overexpression correlates with IGFBP1 upregulation and postnatal dwarfism: evidence for an interaction between Hoxa5 and Forkhead box transcription factors.","volume":"129","author":"Foucher","year":"2002","journal-title":"Development"},{"key":"2020071613105662300_R46","first-page":"E860","article-title":"Total body lipid and triglyceride response to energy deficit: relevance to body composition models","volume":"274","author":"Comizio","year":"1998","journal-title":"Am J Physiol."},{"key":"2020071613105662300_R47","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/hmg\/ddh314","article-title":"Evidence for genetic modifiers of postnatal lethality in PWS-IC deletion mice","volume":"13","author":"Chamberlain","year":"2004","journal-title":"Hum Mol Genet."},{"key":"2020071613105662300_R48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archsurg.138.4.389","article-title":"Roles for ghrelin in the regulation of appetite and body weight","volume":"138","author":"Cummings","year":"2003","journal-title":"Arch Surg."},{"key":"2020071613105662300_R49","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1210\/endo.142.10.8490","article-title":"Minireview: ghrelin and the regulation of energy balance\u2014a hypothalamic perspective.","volume":"142","author":"Horvath","year":"2001","journal-title":"Endocrinology"},{"key":"2020071613105662300_R50","first-page":"313","author":"Nicholls","year":"2003"},{"key":"2020071613105662300_R51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(03)14370-X","article-title":"The paradox of Prader-Willi syndrome: a genetic model of starvation.","volume":"362","author":"Holland","year":"2003","journal-title":"Lancet"},{"key":"2020071613105662300_R52","doi-asserted-by":"crossref","first-page":"513S","DOI":"10.1093\/ajcn\/67.3.513S","article-title":"Fuel partitioning and food intake","volume":"67","author":"Friedman","year":"1998","journal-title":"Am J Clin Nutr."},{"key":"2020071613105662300_R53","doi-asserted-by":"crossref","first-page":"R715","DOI":"10.1152\/ajpregu.00159.2001","article-title":"Interactions of dietary fat and 2,5-anhydro-d-mannitol on energy metabolism in isolated rat hepatocytes","volume":"282","author":"Ji","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"2020071613105662300_R54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.physbeh.2004.01.007","article-title":"Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats","volume":"81","author":"Horn","year":"2004","journal-title":"Physiol Behav."},{"key":"2020071613105662300_R55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0165-3806(94)90222-4","article-title":"Exogenous cholecystokinin activates cFos expression in medullary but not hypothalamic neurons in neonatal rats","volume":"77","author":"Rinaman","year":"1994","journal-title":"Brain Res Dev Brain Res."},{"key":"2020071613105662300_R56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-3806(01)00183-3","article-title":"Gastrointestinal projection maps of the vagus nerve are specified permanently in the perinatal period","volume":"129","author":"Powley","year":"2001","journal-title":"Brain Res Dev Brain Res."},{"key":"2020071613105662300_R57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-0115(00)00142-7","article-title":"Postnatal regulation of hypothalamic neuropeptide expression by leptin: implications for energy balance and body weight regulation","volume":"92","author":"Ahima","year":"2000","journal-title":"Regul Pept."},{"key":"2020071613105662300_R58","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1523\/JNEUROSCI.5369-03.2004","article-title":"Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice","volume":"24","author":"Bouret","year":"2004","journal-title":"J Neurosci."},{"key":"2020071613105662300_R59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1542\/peds.111.4.804","article-title":"Glucose and lipid metabolism in small for gestational age infants at 48 hours of age.","volume":"111","author":"Bazaes","year":"2003","journal-title":"Pediatrics"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/10\/4377\/9022161\/endo4377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/10\/4377\/9022161\/endo4377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T07:58:03Z","timestamp":1626163083000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/146\/10\/4377\/2499924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2005-0371","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,1]]}}}